Hsbc Holdings »

Perspective Therapeutics shares owned by Hsbc Holdings

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Hsbc Holdings from 13F filings

Historical chart of Hsbc Holdings investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Hsbc Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Hsbc Holdings

Quarter filed Position value Share count Share price at filing
2026-06-30 $68k 19k 3.53

More positions owned by Hsbc Holdings

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Micron Technology (MU)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
Taiwan Semiconductor Manufac Sponsored Ads (Principal) (TSM)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)

View all positions for Hsbc Holdings

Top funds holding Perspective Therapeutics

BlackRock
TCG Crossover Management
Commodore Capital
Avidity Partners Management
Millennium Management
Vanguard Capital Management
Affinity Asset Advisors
Citadel Advisors
Spruce Street Capital
Balyasny Asset Management
State Street Corporation
Morgan Stanley
Geode Capital Management
Nantahala Capital Management
Goldman Sachs Group

View all funds holding Perspective Therapeutics